DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

DarioHealth schedules Q2 2026 earnings call; no financials or guidance disclosed.

Risk flags

• ●Disclosure risk is high because the announcement provides no financial data, guidance, or operational metrics, preventing investors from assessing recent performance or trends. This matters because investors cannot make informed decisions until the actual results are released.
• ●Narrative risk is present due to the use of broad, aspirational language about AI capabilities and healthcare outcomes without supporting evidence or quantifiable outcomes. This pattern can lead to misaligned expectations if not substantiated in future disclosures.
• ●Event risk is minimal, as the only forward-looking element is the scheduled earnings release. However, the absence of any early indicators or guidance means investors face a binary information event on August 11th, 2026, with no ability to anticipate results.

Bottom line

This announcement is strictly a notice of DarioHealth Corp.'s upcoming Q2 2026 earnings release and conference call, with no financial results, guidance, or operational updates disclosed. The company's description of its AI-powered healthcare platform is not supported by any outcome data or metrics in this release. Investors have no new information to assess business momentum, profitability, or risk ahead of the August 11th event. The only actionable step is to note the call date and await the actual financial disclosures. The most important takeaway is that this announcement is not actionable for investment decisions until the underlying results are published.

Announcement summary

(NASDAQ:DRIO) DarioHealth Corp. announced that it will release its financial results for the 2nd quarter ended June 30th, 2026 and will host a conference call and webcast at 8:30 a.m. Eastern Time, on Tuesday, August 11th, 2026, before the market opens. The conference call will be hosted by Erez Raphael, Chief Executive Officer, Lara Dodo, Chief Operations Officer, and Chen Franco-Yehuda, Chief Financial Officer. Participants can dial in using 1-800-717-1738 (domestic) or 1-646-307-1865 (international), or use the Call me™ link for instant access. The webcast link is https://viavid.webcasts.com/starthere.jsp?ei=1767650&tp_key=4cfb9bb10d. A replay of the call will be available approximately three hours after completion of the conference call through Tuesday, August 25th, 2026, by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and using replay passcode 1188083. DarioHealth Corp. is described as an AI-powered healthcare technology company with a platform powered by more than 13 billion proprietary longitudinal healthcare data points collected over more than a decade. The company projects the expected date of its earnings release as August 11th, 2026.

Disagree with this article?